US Broker Ratings

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 53.90% Upside Potential

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the healthcare sector, is capturing investor attention with its potential upside of 53.90%, based on current analyst ratings...

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: A Look at a 101% Potential Upside for Savvy Investors

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its substantial potential upside...

Privia Health Group, Inc. (PRVA) Investor Outlook: Eyeing a 42% Potential Upside with Strong Buy Ratings

Privia Health Group, Inc. (NASDAQ: PRVA) stands out in the healthcare sector as a dynamic player in the health information services industry. With its focus on..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Biotechnology Innovator with 44.89% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a pivotal player in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug discovery and..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 164% Potential Upside in Biotech

Immunovant, Inc. (NASDAQ: IMVT) has been capturing investor attention in the biotechnology sector with a staggering potential upside of 164.22%. Specializing in developing monoclonal antibodies for..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A Potential 134% Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company at the forefront of addressing rare kidney and metabolic diseases, is capturing investor attention with its notable growth..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring an 86% Potential Upside in the Healthcare Sector

Investors with a keen eye on the healthcare sector might find Kestra Medical Technologies, Ltd (KMTS) an intriguing opportunity. Despite recent fluctuations, the company is demonstrating..

SS Innovations International (SSII) Stock Analysis: Exploring Growth Potential Amidst Strong Revenue Momentum

SS Innovations International, Inc. (SSII), headquartered in Gurugram, India, is carving a niche in the healthcare sector as a formidable player in the medical devices industry...

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 36% Potential Upside Amid Promising CNS Innovations

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, is garnering attention from investors for its significant potential upside and strategic focus on..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 33.89% Potential Upside and Analyst Consensus

LivaNova PLC (NASDAQ: LIVN), a key player in the medical devices industry, has been capturing the attention of investors with its promising growth prospects and significant..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Report: A 41.73% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a noteworthy player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is capturing investor attention with..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 30.92% Upside Potential in the Healthcare Sector

For investors keen on the healthcare sector, particularly within the niche of non-opioid pain management, Pacira BioSciences, Inc. (NASDAQ: PCRX) presents an intriguing opportunity. As a..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A Strong Buy with a 141% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is garnering significant attention in the biotechnology sector, offering promising opportunities for investors with its focus on developing treatments for serious..

Phreesia, Inc. (PHR) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

Phreesia, Inc. (NYSE: PHR) is carving a niche for itself in the healthcare industry, leveraging its integrated SaaS-based software and payment platform to transform patient engagement..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling a Potential 125.88% Upside in the Biotech Arena

For investors with an eye on the biotechnology sector, Denali Therapeutics Inc. (NASDAQ: DNLI) offers a compelling opportunity. With its focus on developing treatments for complex..

Sotera Health Company (SHC) Stock Analysis: Exploring a 27% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC), a prominent player in the healthcare sector, has caught the attention of investors with its promising potential upside of 27.19%. As..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Healthcare Play with 43% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS) stands out as a compelling investment opportunity within the healthcare sector, particularly in the burgeoning field of cell and gene therapy..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Eyeing a 34.94% Upside with Innovative Urology Solutions

Investors with an eye on the healthcare sector should take a closer look at PROCEPT BioRobotics Corporation (NASDAQ: PRCT), an innovative player in the medical devices..

Addus HomeCare Corporation (ADUS) Stock Analysis: Unlocking a 23.35% Upside Potential in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS) is an intriguing player in the healthcare sector, specializing in providing essential personal care services to some of the most vulnerable..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 31.79% Potential Upside

Guardian Pharmacy Services, Inc (GRDN) is positioned at the intersection of healthcare and technology, providing essential services to long-term care facilities (LTCFs) across the United States...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds